{"disease":{"id":"ocular-hypertension-oh","name":"ocular hypertension oh"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02829996","title":"Study of Fixed-Dose Combinations of Trabodenoson and Latanoprost in Adults With OHT or POAG","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":201,"lead_sponsor_name":"Inotek Pharmaceuticals Corporation","has_results":true},{"nct_id":"NCT06689696","title":"24-hour Wear Performance and Safety Study of Smartlens miLens Contact Lens for IOP Monitoring","phase":"","overall_status":"COMPLETED","enrollment_count":86,"lead_sponsor_name":"Smartlens, Inc.","has_results":false},{"nct_id":"NCT06016972","title":"Qlaris Phase 2 Study of QLS-111 in POAG And/or OHT Patients","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":63,"lead_sponsor_name":"Qlaris Bio, Inc.","has_results":false},{"nct_id":"NCT06249152","title":"Qlaris Study of QLS-111 in Combination With a PGA for OAG and/or OHT Patients","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Qlaris Bio, Inc.","has_results":false},{"nct_id":"NCT05075226","title":"Visual Outcomes of Vivity in Patients With Well Controlled Glaucoma","phase":"","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Maisonneuve-Rosemont Hospital","has_results":false},{"nct_id":"NCT06833060","title":"Transscleral Selective Laser Trabeculoplasty Project","phase":"NA","overall_status":"RECRUITING","enrollment_count":15,"lead_sponsor_name":"Lumibird Medical (Quantel Medical, Ellex Medical, Optotek)","has_results":false},{"nct_id":"NCT06964061","title":"Evaluate Efficacy, Safety, Tolerability and Biodegradation of PA5346 Ocular Implant in Patients With Open-Angle Glaucoma or Ocular Hypertension","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":12,"lead_sponsor_name":"PolyActiva Pty Ltd","has_results":false}],"total":7},"guidelines":[],"source":"Drug Landscape verified database"}